The association of platelet counts with development and treatment for retinopathy of prematurity - is thrombocytopenia a risk factor?

Arch Med Sci · 2022 · PMC8924839 · PMID 35316913

Europe PMC DOI

hedged sentences

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

borderline significancep = 0.052so close (0.05 < p ≤ 0.1)

Multivariate logistic regression analysis suggested that the risk of ROP development increased with the number of days with thrombocytopenia, with borderline significance (OR = 1.097; 95% CI: 0.99–1.21; p = 0.052) and with decreasing gestational age (OR = 0.523; 95% CI: 0.42–0.65; p < 0.001).

also in 7,017 other papers

did not reach statistical significanceno p-value reported

The analyses including platelets transfusions ( p = 0.402), number of platelet transfusions ( p = 0.198), the occurrence of thrombocytopenia before 31 PMA ( p = 0.332), or on the day of birth ( p = 0.844) did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.